This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

Mobile version  RSS  Subscribe  Unsubscribe  Archive  Media Kit

Home   About AST   Education   Meetings & Events   Public Policy   Contact Us   Feb. 7, 2013


Regional variability in liver waiting list removals causes false ascertainment of waiting list deaths
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Authors examine alternative ways of assuring complete documentation of deaths on the Organ Procurement and Transplantation Network (OPTN) Liver Transplant Waiting List and report that the most accurate way is to add to OPTN-reported deaths on the list of all deaths reported in the Social Security Administration Death Master File that occurred within 90 days of a patient's being dropped from the list. More


On demand webinars on the 'Business of Transplantation' and other topics
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Archived versions of the November-January Business of Transplantation webinars are available at AST also offers the Timely Topics in Transplantation catalog of webinars, all available on demand at There are upcoming live webinars in each of these series as well: "Understanding Your Scientific Registry for Transplant Recipients (SRTR) Data" airs at 2 p.m. EST on Wednesday, Feb. 13. Register ahead of time at "New Strategies in Hepatitis Management after Solid Organ Transplantation" airs at 2 p.m. EST on Wednesday, Feb. 20 and registration will open soon at Visit either website for details on webinars in March and beyond!

C1qScreen™: A New Research Tool for AMR Risk
Identify Antibodies That May Compromise Graft Survival
  • Detect Presence of Complement Fixing Antibodies
  • Investigate risk of developing Antibody Mediated Rejection (AMR)
Request a Complimentary Sample Kit!

For Research Use Only. Not for use in diagnostic procedures.

Pay it forward by inviting your colleagues to join AST
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Strengthen the transplant community and get the opportunity to win an iPad or AST bucks when you invite your colleagues to join AST. Pay it forward and tell a colleague why you're a member. You'll help them grow personally and professionally, and you'll be recognized for your referral at ATC, on the AST website, and in AST eNews. For details and guidelines, click here.


COP Executive Committee call for nominations
AST    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Nominations are now being taken for executive committee open positions in 10 Communities of Practice (COPs). The deadline to submit nominations is Feb. 20. To nominate yourself or a fellow colleague, you (the nominator) and the nominee must both be a member of that specific COP. Nominees must be an AST member in good standing. If you need to verify your or the nominee's COP membership, please feel free to contact Jason Polinsky at with your membership verification request. To submit a nomination, simply follow the links to forms for the co-chair positions and committee member-at-large positions.

Athena Diagnostics

Genetic testing can be a cost-effective way to increase the number of living related donor transplants. Mutational analysis may help direct long-term treatment plans, including pre-operative screening of potential kidney transplant recipients and living related donors.
WAVES by Waters Medical Systems
✓ Hypothermic preservation of a single kidney using physiologic pulsatile preservation and membrane oxygenation: a proven technology from Waters Medical Systems (more than 40 years clinical experience) ✓ Simplifies the perfusion process (provides more options to view, chart, and trend data, offers web-based remote monitoring, and a transportable design)
✓ Meets or exceeds current FDA standards and AOPO and UNOS Preservation Guidelines.
MNX: Organ Transportation
When it comes to saving lives, MNX understands organ transplant logistics. Every shipment is urgent, and every step critical. That’s why MNX offers specialty services that are tailored for organ transportation. From expedited ground service to charter flights, MNX has the proven experience and operational resources you can count on.


Uremic pleuritis in chronic hemodialysis patients
Hemodialysis International (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Chronic hemodialysis (HD) patients are predisposed to several complications associated with pleural effusion. In addition, uremia can directly cause pleuritis. However, there are inadequate data about pathogenesis and natural course of uremic pleuritis. In this study, 76 chronic HD patients with pleural effusion were evaluated to figure out the etiology of their pleural disease. More

Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer
Clinical Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Liver transplantation (LT) provides optimal long-term disease-free survival for hepatocellular carcinoma (HCC). High pre-LT alpha-fetoprotein (AFP) has been associated with HCC recurrence, but it is unclear whether a drop in AFP or locoregional therapy impacts survival/recurrence after LT. LT recipients transplanted for HCC in three centers (UNOS Region 6) were reviewed for demographics, tumor characteristics, locoregional therapy, AFP, recurrence and survival. More

Valganciclovir dosing using area under the curve calculations in pediatric solid organ transplant recipients
Pediatric Transplanatation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Pediatric valganciclovir dosing recommendations have not been extensively validated for prevention or treatment for CMV infection. As such, researchers performed a pharmacokinetic study to compare different valganciclovir dosing regimens and the potential benefits of individualized dose adjustments in children following organ transplantation. More

Follow-up of secondary diabetic complications after pancreas transplantation
Current Opinion in Organ Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Patients who are referred for pancreas transplantation usually suffer from advanced chronic complications of diabetes, which have classically been deemed irreversible. A successful pancreas transplantation is often able to slow the progression, stabilize and even reverse many microvascular and macrovascular complications of diabetes. Growing clinical evidence shows that the expected natural history of long-term diabetic complications can be significantly modified by successful pancreas transplantation. More

Put Science on Your Side

Drug Monitoring Platforms since 1981.

Learn More
Exclusively Focused Transplant Pharmacy Therapeutics
Transplant IV Biologics and Oral Immunosuppressives specializing in Desensitization and AMR Treatment and Prevention. MORE

Trends in immunosuppression after pancreas transplantation: What is in the pipeline?
Current Opinion in Organ Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A study was conducted to provide an overview of currently available immunosuppressive strategies and novel therapeutic developments in pancreas transplantation. Implementation of novel therapeutic strategies and combination protocols to reduce or avoid drug toxicities and immune-related complications that are evaluated in prospective and randomized trials is requested to improve outcomes after pancreas transplantation. More

Counseled women can breastfeed while taking tacrolimus
Renal & Urology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Women taking tacrolimus who wish to breastfeed after appropriate counseling should not be discouraged from doing so. John Schieszer reports in the Medical Minute on one of the first studies to look at breastmilk and infant health in women who are taking this immunosuppressant following transplantation. More

Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease
American Journal of Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Obesity is increasingly common before and after liver transplantation (LT), yet optimal management remains unclear. The aim of a recent study was to analyze the effectiveness of a multidisciplinary protocol for obese patients requiring LT, including a noninvasive pretransplant weight loss program and a combined LT plus sleeve gastrectomy for obese patients who failed to lose weight prior to LT. More

Results of the European clinical trial of arrow coraide left ventricular assist system
Artificial Organs (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The aim a recent study was to evaluate the safety and performance of the Arrow CorAide left ventricular assist system, a continuous-flow left ventricular assist device, as bridge to transplantation or recovery as well as destination therapy in patients with New York Heart Association class IV heart failure. More

Living donor smoking worsens recipient survival
Renal & Urology News (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Recipients of kidneys from living donors who smoke have shorter survival than recipients of kidneys from non-smoker living donors, according to a study presented at the American Society of Transplant Surgeons' 2013 Annual State of the Art Winter Symposium. More

AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Courtney Hodges, Content Editor, 972.402.2604   
Contribute news

This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
Jan. 31, 2013
Jan. 24, 2013
Jan. 17, 2013
Jan. 10, 2013

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063